New Alzheimer's agitation treatment shows promise in major trial
NCT ID NCT04947553
Summary
This study tested whether AXS-05 is safe and effective for reducing agitation in people with Alzheimer's disease over a long period. 456 participants who had already shown benefit from AXS-05 in previous studies were either kept on the medication or switched to placebo to see if symptoms returned. The research aimed to determine if the treatment provides lasting relief from the distressing agitation symptoms that often accompany Alzheimer's.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Peoria, Arizona, 83581, United States
-
Clinical Research Site
Tempe, Arizona, 85282, United States
-
Clinical Research Site
Long Beach, California, 90807, United States
-
Clinical Research Site
Santa Ana, California, 92705, United States
-
Clinical Research Site
Temecula, California, 92591, United States
-
Clinical Research Site
Walnut Creek, California, 94596, United States
-
Clinical Research Site
Bonita Springs, Florida, 34134, United States
-
Clinical Research Site
Brandon, Florida, 33511, United States
-
Clinical Research Site
Coral Springs, Florida, 33067, United States
-
Clinical Research Site
Greenacres City, Florida, 33467, United States
-
Clinical Research Site
Hialeah, Florida, 33012, United States
-
Clinical Research Site
Hollywood, Florida, 33024, United States
-
Clinical Research Site
Kissimmee, Florida, 34741, United States
-
Clinical Research Site
Lake City, Florida, 32055, United States
-
Clinical Research Site
Miami, Florida, 33126, United States
-
Clinical Research Site
Miami, Florida, 33135, United States
-
Clinical Research Site
Miami, Florida, 33145, United States
-
Clinical Research Site
Miami, Florida, 33155, United States
-
Clinical Research Site
Miami, Florida, 33165, United States
-
Clinical Research Site
Miami, Florida, 33173, United States
-
Clinical Research Site
Miami, Florida, 33175, United States
-
Clinical Research Site
Miami Gardens, Florida, 33014, United States
-
Clinical Research Site
Miami Lakes, Florida, 33014, United States
-
Clinical Research Site
Orlando, Florida, 32807, United States
-
Clinical Research Site
Pembroke Pines, Florida, 33025, United States
-
Clinical Research Site
Tampa, Florida, 33614, United States
-
Clinical Research Site
Tampa, Florida, 33634, United States
-
Clinical Research Site
Trinity, Florida, 34655, United States
-
Clinical Research Site
Columbus, Georgia, 31909, United States
-
Clinical Research Site
Wichita, Kansas, 67214, United States
-
Clinical Research Site
Braintree, Massachusetts, 02184, United States
-
Clinical Research Site
Flint, Michigan, 48532, United States
-
Clinical Research Site
Rochester Hills, Michigan, 48307, United States
-
Clinical Research Site
Chesterfield, Missouri, 63005, United States
-
Clinical Research Site
Toms River, New Jersey, 08755, United States
-
Clinical Research Site
Brooklyn, New York, 11229, United States
-
Clinical Research Site
New Windsor, New York, 12553, United States
-
Clinical Research Site
Staten Island, New York, 10314, United States
-
Clinical Research Site
Charlotte, North Carolina, 28211, United States
-
Clinical Research Site
Hickory, North Carolina, 28601, United States
-
Clinical Research Site
Austin, Texas, 78737, United States
-
Clinical Research Site
Cypress, Texas, 77429, United States
-
Clinical Research Site
Mesquite, Texas, 75149, United States
-
Clinical Research Site
Sugar Land, Texas, 77478, United States
-
Clinical Research Site
Arlington, Virginia, 22205, United States
-
Clinical Research Site
Kelowna, British Columbia, V1Y 1Z9, Canada
-
Clinical Research Site
San Juan, 00918, Puerto Rico
Conditions
Explore the condition pages connected to this study.